To Evaluate the Pharmacokinetic of Diacerein and Rhein After Maximum Use in Patients With Epidermolysis Bullosa (EB)

Clinical trial NCT03472287 · COMPLETED

Trial details

NCT number: NCT03472287
Sponsor: Castle Creek Pharmaceuticals, LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Epidermolysis Bullosa (EB)Epidermolysis Bullosa Simplex Dystrophic Epidermolysis Bullosa Junctional Epidermolysis Bullosa

Start date: 2018-05-18
Primary completion: 2019-01-31
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.